Clinical trial
A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
NCT00480558 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00480558 |
|---|---|
| Title | A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both |
| Official title | A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Asymptomatic Volunteers Who Are Infected With Either Mycobacterium Tuberculosis (M.tb.), Human Immunodeficiency Virus (HIV) or Both |
| Lead sponsor | University of Oxford, Other |
| Collaborators | University of Cape Town |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections, TB |
| Intervention type | Biological |
| Interventions | MVA 85A |
| Enrollment | 48 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | May 31, 2007 |
| Last update posted | Mar 28, 2011 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: